NETRIAS, LLC — Department of Defense STTR Phase II: ST18C-002

NETRIAS, LLC — STTR Phase II award from Department of Defense.

Amount
$1,999,781
Agency
Department of Defense · Defense Advanced Research Projects Agency
Program / Phase
STTR · Phase II
Topic
ST18C-002
Solicitation
18.C
NAICS
Place of performance
MD
Period
2020-03-23 → 2023-11-30

Description

Netrias, the Texas A&M Health Science Center (TAMHSC) and the Texas A&M Engineering Experiment Station (TEES), and expert consultants will expand and extend the capabilities of PathEngine, an advanced computational platform that ingests and integrates a corpus of bacterial phenotype measurements suitable for the training of a pathogenicity machine learning algorithm. We will enhance the data integration technology and advanced machine learning techniques of PathEngine to rapidly combine and prioritize relevant host and microorganism phenotypic factors to create an accurate, robust, and comprehensive model of pathogenicity for users with little to no computational experience. We will train the platform on 50 additional strains, adding to the 20 strains that were used in Phase I. We will automatically identify and ingest subsets of genomic data from PATRIC, such as virulence factors, and automate the execution of algorithms that are capable of robustly identifying the pathogenic potential of bacteria at >90% accuracy. State-of-the-art methods currently only achieve this accuracy by predicting self-preservation traits using whole genome sequence data.